5 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B Buy
Article Searches
Regeneron, Sanofi Get EC Nod for Label Expansion of Praluent http://www.zacks.com/stock/news/360917/regeneron-sanofi-get-ec-nod-for-label-expansion-of-praluent?cid=CS-ZC-FT-360917 Mar 18, 2019 - Regeneron (REGN) and partner Sanofi receives approval in Europe for the label expansion of Praluent to reduce cardiovascular (CV) risk in adults with established atherosclerotic CV disease.
Roche Gets Approval for Label Expansion of MabThera in Europe http://www.zacks.com/stock/news/359892/roche-gets-approval-for-label-expansion-of-mabthera-in-europe?cid=CS-ZC-FT-359892 Mar 15, 2019 - Roche (RHHBY) gets EC approval for the label expansion of its legacy RA drug, MabThera for pemphigus vulgaris.
AMGN: BMO Capital Markets starts at Outperform http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20190315120125 Mar 15, 2019 - BMO Capital Markets issues rating change for AMGN
BMO likes Amgen and Gilead in premarket analyst action https://seekingalpha.com/news/3443196-bmo-likes-amgen-gilead-premarket-analyst-action?source=feed_news_all Mar 15, 2019 - Agilent (NYSE:A) initiated with Buy rating and $92 (14% upside) price target at UBS.Amgen (NASDAQ:AMGN) initiated with Outperform rating and $228 (21% upside) at BMO.Fluidigm (NASDAQ:FLDM) initiated w
Roche Receives EC Approval for Label Expansion of Hemlibra http://www.zacks.com/stock/news/359564/roche-receives-ec-approval-for-label-expansion-of-hemlibra?cid=CS-ZC-FT-359564 Mar 14, 2019 - Roche (RHHBY) gets approval from European Commission for a label expansion of hemophilia drug, Hemlibra.

Pages: 1

Page 1

Related Companies

Name Exchange Price Mkt Cap
GILD Gilead Sciences, Inc. NASDAQ $72.78 $94.35B
BIIB Biogen Inc. NASDAQ $334.44 $67.37B
SGEN Seattle Genetics, Inc. NASDAQ $76.15 $12.09B
NBIX Neurocrine Biosciences, Inc. NASDAQ $117.38 $10.62B
QGEN Qiagen N.V. NASDAQ $37.42 $8.5B
Sector: Health Care > Industry: Biotechnology: Biological Products (No Diagnostic Substances)
DeepLinks for Amgen
AMGN - Google Finance https://www.google.com/finance?q=AMGN Industry related info and international coverage Summary News
AMGN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=AMGN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options